Aim: To outline the role of customized solutions in post-COVID mucormycosis by reconstructing one’s lost facial structures and to mark a transformative leap in the field of personalized medicine that ensures optimal functionality and aesthetics.
Summary: Post-COVID mucormycosis left individuals with huge maxillofacial defects, a heavy financial burden, and emotional scars for life. Rehabilitation of such patients is our duty as maxillofacial surgeons to give them back their lost aesthetics, function, and self-confidence. The need for customized implants that anchor the adjacent residual zygomatic, pterygoid, nasal, and orbital floors provide better results than conventional implants. Being aware of the challenges in rehabilitating post-COVID rhino-maxillary mucormycosis patients ( lack of maxillary bone (including pterygoid plate and/or zygomatic bone), adhesion of nasal and sinus mucosa with palatal mucosa with fibrosed palatal mucosa, loss of lip support, reduced stress bearing area, lack of vertical guidance, over closure of the mandible, etc), patient-specific zygomatic implants offer efficient stability and function, expediting recovery with minimal morbidity.
Conclusion and Inference: PSIs post-COVID offer positive outcomes, ensuring no deep scar on the patient’s dignity and self-confidence. Even after 12 weeks and 4 weeks of follow-up, respectively, no implant-related complications were observed. In the future, custom PSI stands as a precise alternative; CAD/CAM technology drives a step closer in the fabrication of custom implants.
Parole chiave: patient-specific implant , post-COVID mucormycosis , CAD/CAM technology
